Cargando…
Diagnosis of gluten-related enteropathy in a newborn: how and when?
AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820841/ https://www.ncbi.nlm.nih.gov/pubmed/31749915 |
_version_ | 1783464029069508608 |
---|---|
author | Assandri, Roberto Montanelli, Alessandro |
author_facet | Assandri, Roberto Montanelli, Alessandro |
author_sort | Assandri, Roberto |
collection | PubMed |
description | AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first year of life is uncommon, which is due to the suboptimal sensitivity of tissue transglutaminase IgA antibodies (tTG-IgA) at this age and other possible causes of malabsorption in infants. The development of Deamidate gliadin peptide-specific antibodies (in particular DGP-IgG) in young children was poorly considered in the CD diagnosis. METHODS: We conducted a retrospective cross-sectional study on children between one month and forty-eight months of life, which performed in our health center from 2016 to 2018. Three hundred and fifty children were selected according to strict inclusion criteria: positive for HLA-DQA1 and DQB1 alleles, positive anti tTG-IgA/IgG and/or positive DGP-IgG/IgA. Eighty-two children were selected and divided into two different groups of patients: Group one (forty newborns under twenty-four months of life) and Group two (children from twenty-five months to 48 months of life). RESULTS: Anti-DGP-IgG antibodies precede anti tTG-IgA seroconversion in children under two years in 80% of cases. Anti-DGP-IgG positive patients had milder symptomatic forms of CD than anti tTG-IgA positive children, characterized by gastrointestinal symptoms in the presence of normal growth, normal serum iron, and low MCH level. At tTG-IgA seroconversion, children present gastrointestinal clinical forms associated with impaired growth. The combined use of tTG-IgA and DGP-IgG antibodies upgrade the diagnostic sensitivity from 50% to 92%. CONCLUSION: Anti-DGP-IgG antibodies precede tTG-IgA seroconversion in newborns and identified two distinct clinical phenotypes. At this point, if you wanted to test your newborn patients for CD serology, how would you proceed? |
format | Online Article Text |
id | pubmed-6820841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-68208412019-11-20 Diagnosis of gluten-related enteropathy in a newborn: how and when? Assandri, Roberto Montanelli, Alessandro Gastroenterol Hepatol Bed Bench Original Article AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first year of life is uncommon, which is due to the suboptimal sensitivity of tissue transglutaminase IgA antibodies (tTG-IgA) at this age and other possible causes of malabsorption in infants. The development of Deamidate gliadin peptide-specific antibodies (in particular DGP-IgG) in young children was poorly considered in the CD diagnosis. METHODS: We conducted a retrospective cross-sectional study on children between one month and forty-eight months of life, which performed in our health center from 2016 to 2018. Three hundred and fifty children were selected according to strict inclusion criteria: positive for HLA-DQA1 and DQB1 alleles, positive anti tTG-IgA/IgG and/or positive DGP-IgG/IgA. Eighty-two children were selected and divided into two different groups of patients: Group one (forty newborns under twenty-four months of life) and Group two (children from twenty-five months to 48 months of life). RESULTS: Anti-DGP-IgG antibodies precede anti tTG-IgA seroconversion in children under two years in 80% of cases. Anti-DGP-IgG positive patients had milder symptomatic forms of CD than anti tTG-IgA positive children, characterized by gastrointestinal symptoms in the presence of normal growth, normal serum iron, and low MCH level. At tTG-IgA seroconversion, children present gastrointestinal clinical forms associated with impaired growth. The combined use of tTG-IgA and DGP-IgG antibodies upgrade the diagnostic sensitivity from 50% to 92%. CONCLUSION: Anti-DGP-IgG antibodies precede tTG-IgA seroconversion in newborns and identified two distinct clinical phenotypes. At this point, if you wanted to test your newborn patients for CD serology, how would you proceed? Shaheed Beheshti University of Medical Sciences 2019 /pmc/articles/PMC6820841/ /pubmed/31749915 Text en ©2019 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Assandri, Roberto Montanelli, Alessandro Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title | Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title_full | Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title_fullStr | Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title_full_unstemmed | Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title_short | Diagnosis of gluten-related enteropathy in a newborn: how and when? |
title_sort | diagnosis of gluten-related enteropathy in a newborn: how and when? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820841/ https://www.ncbi.nlm.nih.gov/pubmed/31749915 |
work_keys_str_mv | AT assandriroberto diagnosisofglutenrelatedenteropathyinanewbornhowandwhen AT montanellialessandro diagnosisofglutenrelatedenteropathyinanewbornhowandwhen |